Department of Genetics, Bhagwan Mahavir Hospital and Research Centre, Hyderabad, Andhra Pradesh, India.
J Diabetes. 2009 Jun;1(2):118-24. doi: 10.1111/j.1753-0407.2009.00025.x.
Diabetic nephropathy (DN) is a devastating complication of diabetes, the exact molecular pathophysiology of which is not well established. Hyperglycemia increases insulin-like growth factors (IGFs), especially IGF2, which acts via the IGF1 receptor present on renal cells. Elevated glucose levels damage the kidney, which is repaired by modulators such as secreted protein acidic and rich in cysteine (SPARC). Hence, it was hypothesized that IGF2 and SPARC may have an important role in the etiology of DN.
Human renal biopsies, histopathologically categorized as normal, early Type 2 diabetes mellitus (T2DM), or established DN, were analyzed for the localization and expression of IGF2, its negative regulator phosphatase and tensin homolog on chromosome 10 (PTEN), and SPARC.
Expression of IGF2, PTEN, and SPARC was increased in renal biopsies from T2DM patients compared with normal samples. Although IGF2 protein was increased in biopsies from DN patients, PTEN and SPARC levels were decreased. Real-time reverse transcription-polymerase chain reaction indicated that transcript levels of IGF2 and PTEN were greater than those of β-actin in all human renal biopsy samples.
The results suggest the following molecular etiopathophysiology of DN: (i) hyperglycemia upregulates IGF2, which initiates PTEN, a regulator of IGF2 signaling; (ii) loss of this IGF2-PTEN feedback loop causes changes that are characteristic of DN; and (iii) lowered expression of the repair modulator SPARC results in the development and/or progression of DN. Hence, targeting relevant modulators, such as like IGF2, PTEN, and SPARC, may be important in the management of DN.
糖尿病肾病(DN)是糖尿病的一种严重并发症,其确切的分子病理生理学尚未完全确定。高血糖会增加胰岛素样生长因子(IGFs),尤其是 IGF2,后者通过存在于肾细胞上的 IGF1 受体发挥作用。升高的葡萄糖水平会损害肾脏,而修复则由分泌富含半胱氨酸的酸性蛋白(SPARC)等调节剂完成。因此,人们假设 IGF2 和 SPARC 可能在 DN 的发病机制中起重要作用。
对组织病理学分类为正常、早期 2 型糖尿病(T2DM)或已确诊的 DN 的人类肾活检组织进行分析,以确定 IGF2、其在 10 号染色体上的负调节剂磷酸酶和张力蛋白同源物(PTEN)和 SPARC 的定位和表达。
与正常样本相比,T2DM 患者的肾活检组织中 IGF2、PTEN 和 SPARC 的表达增加。尽管 DN 患者的活检组织中 IGF2 蛋白增加,但 PTEN 和 SPARC 水平降低。实时逆转录聚合酶链反应表明,在所有人类肾活检样本中,IGF2 和 PTEN 的转录水平均大于 β-肌动蛋白。
研究结果表明 DN 的以下分子发病机制:(i)高血糖上调 IGF2,从而启动 IGF2 信号的调节剂 PTEN;(ii)丧失这种 IGF2-PTEN 反馈环会导致出现 DN 的特征性变化;(iii)修复调节剂 SPARC 的表达降低会导致 DN 的发生和/或进展。因此,针对相关调节剂(如 IGF2、PTEN 和 SPARC)可能对 DN 的治疗很重要。